ARCHIVES

In Brief: Deisseroth Leaves M.D. Anderson To Head Yale’s Oncology, Gene Therapy Programs

This article is from The Cancer Letter archive.

Vol. 21 No. 35 | September 15, 1995

Download PDF Visit The Full Archive

Related Articles

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

January 31, 2014

Cancer Webmasters Seek to Develop Tools for Greater Use of NCI Cancer Information

May 5, 2000

In Brief: Breast Cancer Projects To Pay For Concurrent Pathology Review; Laetrile Study Entry Closed

May 19, 1978

Frelick To Receive ACCC Annual Award Will Leave NCI In July

March 6, 1987

Lasker Awards Announced

September 25, 2009

Biopsies Could Be Reduced By Computer-Aided-Detection

December 26, 2003